Which Factors Will Push The Scleritis Market To Achieve $5.49 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Scleritis Market In The Coming Years?
The scleritis market has seen considerable growth in recent years. The size of the market is forecasted to expand from $3.6 billion in 2024 to $3.93 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.0%. This steadily increasing trend can be credited to factors such as an upswing in autoimmune disorders, heightened understanding of eye health, the growing aging population, better accessibility to eye care, and broader global healthcare facilities.
The market for scleritis is projected to witness robust growth over the coming years, expanding to a valuation of $5.49 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. This predicted growth during the forecasted period is due to increasing eye-related health issues, heightened ocular health awareness, growing healthcare expenses, broadening research in ophthalmology, escalating demand for individualized medicine, and an increase in treatment precedence. Key trends anticipated during this period include the creation of specific biologic therapies, enhanced immunosuppressive drug compounds, technological advancements in imaging, the employment of minimally invasive diagnostic instruments, the application of personalized medicine strategies, advancements in drug delivery systems, and the use of AI-powered diagnostic and treatment planning solutions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp
Which Growth Drivers Are Shaping The Scleritis Market Outlook?
The escalating incidences of autoimmune diseases are anticipated to fuel the expansion of the scleritis market in the future. Autoimmune diseases occur when the body’s immune system erroneously assaults its own healthy cells and tissues, misinterpreting them as alien threats. This increase in autoimmune diseases can be attributed to genetic predispositions, environmental influences, changes in lifestyle, and heightened awareness leading to improved diagnosis. These diseases result in scleritis when they ignite an inflammatory immune reaction that by mistake attacks the scleral tissue, causing pain and redness. For instance, the Versorgungsatlas.de, a German-based organization, reported in November 2024 that out of 73,241,305 insured individuals in 2022, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a crude prevalence rate of 8.61%. Hence, the augmenting incidences of autoimmune diseases are propelling the development of the scleritis market.
What Is The Segment Breakdown Of The Scleritis Market?
The scleritismarket covered in this report is segmented –
1) By Type: Anterior Scleritis; Posterior Scleritis; Other Types
2) By Treatment: Medication; Surgery; Other Treatment
3) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channel
4) By End-Users: Hospitals; Specialty Clinics; Home Healthcare; Other End-Users
Subsegments:
1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis; Necrotizing Anterior Scleritis
2) By Posterior Scleritis: Diffuse Posterior Scleritis; Nodular Posterior Scleritis; Scleritis With Choroidal Involvement
3) By Other Types: Chronic Scleritis; Recurrent Scleritis; Infectious Scleritis
How Are Global Trends Impacting The Development Of The Scleritis Market?
In the scleritis market, prominent companies are advancing products like eye drops to address inflammation with convenient, non-invasive treatments. Eye drops deliver medication directly to the eyes to manage conditions such as irritation, dryness, inflammation, or infection. For example, in May 2023, India’s Entod Pharmaceuticals launched CYCLOTEARS eye drops both domestically and internationally. This innovative treatment incorporates proprietary SEDDS technology, improving drug delivery and efficacy to treat inflammatory eye diseases like dry eye disease, ocular myositis, and scleritis.
Who Are The Major Stakeholders Operating In The Scleritis Market?
Major companies operating in the scleritis market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceuticals USA Inc., Baxter International Inc., Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd., Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West-Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Zydus Pharmaceuticals Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report
Which Region Is Likely To Register The Fastest Growth In The Scleritis Market?
North America was the largest region in the scleritis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21283&type=smp
Browse Through More Reports Similar to the Global Scleritis Market 2025, By The Business Research Company
Arthritis Monoclonal Antibodie Global Market Report 2025
Psoriatic Arthritis Treatments Global Market Report 2025
Companion Animal Arthritis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
